Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MT-CO2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
mRNA | TNKS1BP1 | CCLE | pan-cancer | AAC | 0.23 | 3e-05 |
mRNA | PHLDA1 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | ITGB6 | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
mRNA | GJB5 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
mRNA | MARVELD3 | CCLE | pan-cancer | AAC | 0.25 | 3e-05 |
mRNA | IFFO1 | CCLE | pan-cancer | AAC | -0.33 | 3e-05 |
mRNA | EPHA1 | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
mRNA | AP1S2 | CCLE | pan-cancer | AAC | -0.24 | 4e-05 |
mRNA | LANCL2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |